Sunday, August 5, 2012

FDA approves Zaltrap for metastatic colorectal cancer | Recall ...

The U.S. Food and Drug Administration today approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

This is a summary of a Press Release issued by the Food and Drug Administration (FDA). The link below will take you to the original press release containing complete information, including instructions about what to do if you are affected.

View Full Details Of Original FDA Press Release Here.

Source: http://www.recallnewsletter.com/fda-approves-zaltrap-for-metastatic-colorectal-cancer

dez bryant Kitty Wells Marissa Mayer Jon Lord weather.com cnn yahoo news

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.